Following Astorg’s take-private of Hamilton Thorne, and simultaneous acquisition of Cook Medical’s Reproductive Health business, the newly combined global assisted reproductive technology (ART) business has signed a definitive agreement to acquire the Medical Media Business from FUJIFILM Irvine Scientific, a manufacturer of cell culture solutions for the life science and medical markets. FUJIFILM Irvine Scientific MBU provides products including culture and vitrification media for in-vitro fertilization (IVF), infertility research, and cytogenetic analysis.
European PE firm, Astorg is bringing the three businesses together creating a new global ART MedTech company with a new brand identity for the combined businesses being rolled out this year.
“This strategic add-on acquisition of a leading portfolio of ART media further strengthens the combined company’s ability to support fertility professionals, clinics, laboratories, and patients by delivering advanced solutions that improve fertility outcomes,” said Judith Charpentier, co-head of Flagship Fund and head of Healthcare, Astorg.
The combination will provide fertility clinics and IVF laboratories with a portfolio of products designed to enhance outcomes and increase accessibility to fertility treatments worldwide.
The sale allows FUJIFILM Irvine Scientific to focus on its life sciences businesses.
Astorg, FUJIFILM Irvine Scientific, and the management of the combined businesses led by Wil Boren are working on integration plans including significant additional investment by Astorg focused on offering fertility clinics and IVF laboratories ‘high quality, innovative and industry leading products’.
Financial terms were not disclosed.
